acheter cialis


The past decade has seen a significant shift in the nature of the products being manufactured and sold by the innovative biopharmaceutical (biopharma) industry. The global biopharmaceutical portfolio of today reflects increased therapeutic competition, a greater prevalence of large molecule drugs, expansion in the number of personalized or targeted products, and a rise of treatments for many orphan diseases. These trends have given rise to biopharmaceutical products with extremely limited production runs, highly specific manufacturing requirements, and genotype-specific products. This fundamental shift in the overall product mix and a focus on continuing to improve the efficiency and effectiveness of production is spurring an evolution in the technologies and processes needed to support advanced biopharmaceutical manufacturing. Innovation in manufacturing technology is helping to drive improved economics, flexibility and quality while potentially benefiting patients both directly and indirectly

The changes in biopharmaceutical portfolios and the rise of advanced manufacturing technologies have impacts both inside and outside of biopharma companies. First, they are driving biopharma companies to seek increasingly specialized workers who possess needed experience and skills. As a result, organizations are helping to design training programs at university biomanufacturing centers devoted to teaching relevant skills to students and employees. Second, the changes are causing biopharma companies to work collaboratively on manufacturing innovation through partnerships with academic institutions, diagnostics developers, production equipment manufacturers, and medical device manufacturers. Third, the new portfolios and technologies required are giving biopharma companies more reasons to consider location and ecosystem advantages in their strategic decisions around manufacturing. Finally, the rise of biopharmaceutical advanced manufacturing technologies is positively impacting society by benefiting patients, the environment, and the nation’s standing as a leader in innovation — perhaps even enhancing overall U.S. competitiveness.